These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Functional imaging of the brain using low dose gadolinium-DTPA and Turbo-FLASH sequences]. Hackländer T, Hofer M, Paselk C, Mödder U. Rofo; 1993 Apr; 158(4):348-54. PubMed ID: 8477076 [Abstract] [Full Text] [Related]
3. [Oral contrast media for magnetic resonance tomography of the abdomen. III. Initial patient research with gadolinium-DTPA]. Claussen C, Kornmesser W, Laniado M, Kaminsky S, Hamm B, Felix R. Rofo; 1988 Jun; 148(6):683-9. PubMed ID: 2837806 [Abstract] [Full Text] [Related]
4. [Gadolinium-DTPA in the study of intracranial tumors in the adult]. Grégoire N, Momose T, Rumeau C, Perot S, Girard N, Lavanga A, Salamon G. Rev Neurol (Paris); 1990 Jun; 146(2):133-43. PubMed ID: 2320818 [Abstract] [Full Text] [Related]
5. [Gadolinium-DTPA as an oral contrast medium for magnetic resonance tomography of the pancreas]. Neumann K, Kaminsky S, Gogoll M, Clauss W, Langer M, Felix R. Rofo; 1991 Mar; 154(3):262-8. PubMed ID: 1849293 [Abstract] [Full Text] [Related]
7. [Space-occupying lesions in the pineal region--MRT using Gd-DTPA]. Kahn T, Fürst G, Roosen N, Steinmetz H, Lenard HG, Göbel U, Mödder U. Rofo; 1989 Jun; 150(6):657-62. PubMed ID: 2544939 [Abstract] [Full Text] [Related]
8. [Contrast-enhanced MR imaging using double doses of gadolinium-DTPA in evaluating brain and spinal diseases]. Matsumoto S, Hasuo K, Uchino A, Matsuura Y, Gibo M, Fukui M, Masuda K. Nihon Igaku Hoshasen Gakkai Zasshi; 1993 May 25; 53(5):503-10. PubMed ID: 8327315 [Abstract] [Full Text] [Related]
9. [Magnetic resonance tomographic studies of paragangliomas of the glomus caroticum and glomus jugulare using Gd-DTPA]. Vogl T, Bauer M, Schedel H, Brüning R, Mees K, Lissner J. Rofo; 1988 Jan 25; 148(1):38-46. PubMed ID: 2829304 [Abstract] [Full Text] [Related]
10. [Gadolinium DTPA in magnetic resonance. Clinical experience in intracranial pathology]. Bradac GB, Riva A, Berger T, Stura G, Duca S. Radiol Med; 1988 Jan 25; 76(1-2):33-7. PubMed ID: 3399707 [Abstract] [Full Text] [Related]
11. [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types]. Yoshida K, Furuse M, Kaneoke Y, Sasou K, Motegi Y. No To Shinkei; 1988 Jun 25; 40(6):531-7. PubMed ID: 3224029 [Abstract] [Full Text] [Related]
12. [Initial experience with the use of oral gadolinium-DTPA in nuclear magnetic resonance tomography of the pelvis]. Hötzinger H, Salbeck R, Toedt C, Beyer HK. Digitale Bilddiagn; 1990 Jun 25; 10(2):42-5. PubMed ID: 2208914 [Abstract] [Full Text] [Related]
13. [Contrast-enhanced MRT of malignant melanoma of the uvea]. Adam G, Brab M, Bohndorf K, Klose KC, Günther RW. Rofo; 1991 Mar 25; 154(3):275-80. PubMed ID: 1849295 [Abstract] [Full Text] [Related]
16. [The diagnosis of bladder carcinomas by NMR tomography: an improvement with Gd-DTPA?]. Sparenberg A, Hamm B, Hammerer P, Samberger V, Wolf KJ. Rofo; 1991 Aug 25; 155(2):117-22. PubMed ID: 1878537 [Abstract] [Full Text] [Related]
17. [Double-dose Gd-DTPA: detectability of intraparenchymal brain metastasis]. Tatsuno S, Hata Y, Tada S. Nihon Igaku Hoshasen Gakkai Zasshi; 1996 Oct 25; 56(12):855-9. PubMed ID: 8940816 [Abstract] [Full Text] [Related]
18. [Gd-DTPA in the diagnosis of brain metastasis]. Kornienko VN, Pronin IN. Vestn Rentgenol Radiol; 1994 Oct 25; (5):5-10. PubMed ID: 7785209 [Abstract] [Full Text] [Related]
19. [MRT of bladder carcinoma: tumor staging and gadolinium contrast behavior]. Doringer E, Joos H, Forstner R, Schmoller H. Rofo; 1991 Apr 25; 154(4):357-63. PubMed ID: 1850149 [Abstract] [Full Text] [Related]
20. [Brain and spinal tumors: magnetic resonance imaging using gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA)]. Fang YX. Zhonghua Yi Xue Za Zhi; 1989 Jun 25; 69(6):305-7, 22. PubMed ID: 2804747 [Abstract] [Full Text] [Related] Page: [Next] [New Search]